Therefore, evidence concerning the impact of pregnancy as well as its co‐morbidities on COVID‐19–related maternal mortality is still uncertain.
Moreover, new findings from studies conducted in low‐resource countries showed an increased risk of death in obstetric patients who tested positive for SARS‐CoV‐2. On the contrary, women of reproductive age are expected to have 60% less access to intensive care units (ICUs) than postmenopausal women. For this reason, they could be more exposed to contagion than nonpregnant women. However, it is ascertained that pregnant women cannot avoid mandatory examinations therefore, they cannot avoid interactions with healthcare professionals.
Nevertheless, it seems that pregnancies affected by COVID‐19 do not develop more severe symptoms compared to the general population and an increased risk for pregnant women, compared to non‐pregnant women, has not been demonstrated yet. The morbidity rate of COVID‐19 in pregnant women is higher than MERS, SARS, and also influenza and Ebola. The reported mortality for SARS‐Cov‐2 is estimated in the range of 1%–2%, less than other coronaviruses including Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS), for which the reported rate of death is estimated at about 35% and 10%, respectively. The severity of the disease ranges from asymptomatic to acute respiratory distress. Specific consequences of the infection on pregnancy and neonatal outcomes are still uncertain since evidence regarding the disease is still ongoing. The clinical course of the disease frequently starts with low‐grade fever, cough, anosmia, ageusia, headache, chest pain, or pneumonia. To date, the disease is still causing harmful consequences in almost every country. COVID‐19 was declared a pandemic by WHO on March 11, 2020, during its 51st situation report.
0 kommentar(er)
